Scott McAuley
Stock Analyst at Paradigm
(0.25)
# 4,525
Out of 4,988 analysts
15
Total ratings
15.8%
Success rate
-20%
Average return
Main Sectors:
Stocks Rated by Scott McAuley
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TSXV: PINK Perimeter Medical Imaging AI, Inc. | Reiterated: Buy | $1.50 → $0.95 | $0.29 | +233.33% | 4 | Apr 8, 2026 | |
| NGEN NervGen Pharma | Reiterated: Buy | $6.93 | $2.05 | n/a | 3 | Jun 17, 2025 | |
| TSX: GUD Knight Therapeutics Inc. | Reiterated: Hold | $7.50 → $5.30 | $10.25 | n/a | 3 | May 15, 2023 | |
| ZYME Zymeworks | Reiterated: Buy | $24 → $15 | $26.57 | n/a | 4 | May 15, 2023 | |
| TSX: EDT Spectral Medical Inc. | Reiterated: Buy | n/a | $1.18 | n/a | 1 | Apr 7, 2022 |
Perimeter Medical Imaging AI, Inc.
Apr 8, 2026
Reiterated: Buy
Price Target: $1.50 → $0.95
Current: $0.29
Upside: +233.33%
NervGen Pharma
Jun 17, 2025
Reiterated: Buy
Price Target: $6.93
Current: $2.05
Upside: n/a
Knight Therapeutics Inc.
May 15, 2023
Reiterated: Hold
Price Target: $7.50 → $5.30
Current: $10.25
Upside: n/a
Zymeworks
May 15, 2023
Reiterated: Buy
Price Target: $24 → $15
Current: $26.57
Upside: n/a
Spectral Medical Inc.
Apr 7, 2022
Reiterated: Buy
Price Target: n/a
Current: $1.18
Upside: n/a